Division of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu 610041, China.
Division of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu 610041, China; Collaborative Innovation Center of Biotherapy, Chengdu 610041, China.
STAR Protoc. 2022 Dec 16;3(4):101882. doi: 10.1016/j.xpro.2022.101882. Epub 2022 Nov 23.
Interactions between effectors and their host targets are often weak or transient, making them difficult to identify. We describe a protocol for covalent capture of effector substrates in living cells using genetic code expansion technology. The effector-substrate complexes are captured by the crosslinker and subsequently purified with tandem chromatography. We detail steps for mass spectrum analysis and substrate verification. While the steps here are specific for substrates of enteropathogenic E. coli in HEK293T cells, the protocol has broader applications. For complete details on the use and execution of this protocol, please refer to Li et al. (2021)..
效应物与其宿主靶标的相互作用通常较弱或短暂,因此难以识别。我们描述了一种使用遗传密码扩展技术在活细胞中共价捕获效应物底物的方案。效应物-底物复合物被交联剂捕获,然后通过串联层析进行纯化。我们详细介绍了质谱分析和底物验证的步骤。虽然这里的步骤是针对肠致病性大肠杆菌在 HEK293T 细胞中的底物的,但该方案具有更广泛的应用。有关此方案的使用和执行的完整详细信息,请参阅 Li 等人。(2021)。